Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001079973-11-000702
Filing Date
2011-08-22
Accepted
2011-08-22 16:36:06
Documents
11
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q capsalus_10q-063011.htm 10-Q 629744
2 capsalus.jpg GRAPHIC 2547
3 EXHIBIT 31.1 ex31x1.htm EX-31.1 11206
4 EXHIBIT 31.2 ex31x2.htm EX-31.2 10612
5 EXHIBIT 32 ex32.htm EX-32 6014
  Complete submission text file 0001079973-11-000702.txt   1981348

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT well-20110630.xml EX-101.INS 193475
7 XBRL TAXONOMY EXTENSION SCHEMA well-20110630.xsd EX-101.SCH 13363
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE well-20110630_cal.xml EX-101.CAL 35086
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE well-20110630_def.xml EX-101.DEF 8424
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE well-20110630_lab.xml EX-101.LAB 92613
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE well-20110630_pre.xml EX-101.PRE 69502
Mailing Address 2675 PACES FERRY ROAD SUITE 100 ATLANTA GA 30339
Business Address 2675 PACES FERRY ROAD SUITE 100 ATLANTA GA 30339 888-400-7179
CAPSALUS CORP (Filer) CIK: 0000949189 (see all company filings)

EIN.: 880338837 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-146744 | Film No.: 111050212
SIC: 2835 In Vitro & In Vivo Diagnostic Substances